Pune: The phase III trial of RotaVac, India's first indigenously developed rotavirus vaccine, has been completed and the...
Singapore: The Indian Health Ministry has banned the blockbuster diabetes drug Actos along with suspending sales of pain...
Mumbai: Recognizing India as a model for the global vaccine market, the Biotechnology Industry Organization (BIO) has pl...
Pune-based Serum Institute of India (SIIL), one of the largest providers of affordable quality vaccines in the world, ha...
Tokyo: The 7th in-Pharma Japan and 26th Interphex Japan, which are being concurrently held at Tokyo Big Sight, Japan, k...
New Delhi: Ranbaxy Laboratories has reported a 55 percent growth in sales revenue in the second quarter of 2012 over the...
Towards the end of November 2010, Cipla, a Mumbai-based pharmaceutical major, took a step ahead in revolutionizing HIV/A...
Singapore: US-based Intrexon, a synthetic biology company, has appointed Dr Peter Seufer-Wasserthal as VP, business deve...
Bangalore: LifeCell International, India's largest and most accredited stem cell storage company announced its partnersh...
Mumbai: A new introductory course on clinical research has been introduced at the Harvard School of Public Health (HSPH)...
New Delhi: The legal battles between pharma MNCs and local drug companies doesn't seem to cease in India. Following the ...
Mumbai: At the recently held, DIA IT Life Sciences Summit 2012, a host of current topics were discussed at length among ...
Singapore: Breaking its silence for the first time in 10 days after Indian drug major Ranbaxy's $500 million settlement ...
India's Council of Scientific and Industrial Research (CSIR) celebrated 70 years of existence this year. An organization...
Dr Yusuf K Hamied, CMD of India's largest pharma company, Cipla, has earned many unflattering epithets for building a co...
The drug discovery outsourcing market will experience high revenue growth from 2013-to-2023. Expansion of the market wil...
Bangalore: "India stands one among the top 10 league of countries in the Global Innovation Efficiency Index which shows ...
Singapore: India based Private equity (PE) major Actis Capital is said to be considering a sale of Ahmedabad-based Sterl...
